Biomotum, Inc.

Portland, OR

UEI
UNLZML1XMU98
CAGE
8FS19
Primary NAICS
339112 Surgical and Medical Instrument Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
3025 SW 1st Ave, Portland, OR 97201, USA
Website
biomotum.com
Founded
2019
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
59 Miscellaneous Retail
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $0
FY2023 $80,900

Contract awards

Award Agency Obligated Awarded
Biomotum sparks battery powered ankle exoskeletons 36C26323P0960 Veterans Integrated Service Network 23 (VHA) $80,900

Grant awards

Grant subawards

Prime recipient Prime award Amount Awarded
The General Hospital Corporation BPMT Milestones for Biomotum Year 1: Define user needs, product requirements and build initial prototypes 1. Need Statement: 25 families and 25 PTs complete… U54EB033650 $2,191,528

Similar vendors

About the company

Biomotum, Inc. is a manufacturer of robotic exoskeletons that assist individuals living with stroke and cerebral palsy. As described on its website, Biomotum's rehabilitation systems provide assistance and resistance to help users live healthier and more productive lives.

Through federal contracts, Biomotum has supplied proprietary exoskeleton technology to support research efforts by government agencies like the Department of Veterans Affairs. In August 2023, the VA awarded Biomotum an $80,900 firm fixed price purchase order to provide a Biomotum Spark Adult Research System package, which includes a portable, battery-powered ankle exoskeleton to aid mobility research by the Omaha VA Research Department. This award had no set-aside designation or identified subcontractors.

Through federal grants, Biomotum has received funding from agencies like the National Institutes of Health (NIH) to develop innovative orthotic devices that improve mobility and maintain muscle engagement for individuals with cerebral palsy. A recent $274,282 project grant from the NIH's National Institute of Child Health and Human Development aims to design and validate an Adjustable Stiffness Ankle Foot Orthosis that enhances plantar flexor push-off power, ankle range of motion, and muscle activity during walking for cerebral palsy patients. Additionally, a $4.5 million NIH grant awarded in 2020 supports the development of a robotic ankle assist device to improve mobility in individuals with movement disorders. Biomotum does not appear to have partnered with sub-awardees on these grants.

Quick answers

Is Biomotum, Inc. registered in SAM.gov?

Yes. Biomotum, Inc.'s SAM.gov registration is active through March 6, 2027.

What is Biomotum, Inc.'s CAGE code?

Biomotum, Inc.'s CAGE code is 8FS19, and its Unique Entity ID (UEI) is UNLZML1XMU98.

How much has Biomotum, Inc. received in federal contracts?

Federal contracts obligated $80,900 to Biomotum, Inc. in fiscal years 2023 through 2027.

What is Biomotum, Inc.'s most recent federal award?

Biomotum, Inc.'s most recent federal contract award is Biomotum sparks battery powered ankle exoskeletons (36C26323P0960), from Veterans Integrated Service Network 23 (VHA), on August 25, 2023.

On GovTribe

See Biomotum, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe